Malik Shahzad

Director at Versartis, Inc.; Director at AGEN; Director, 10% owner at Conatus Pharmaceuticals Inc

Sold, on record
$19.8M
Dollars the filings state
Form 4 sales
4
Latest Mar 17, 2017
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale Conatus Pharmaceuticals IncPlan not stated
    Jul 30, 2013 2013

    Sold 535 shares at $11.00 ($6k)

    Malik Shahzad, Director, 10% owner

    Sold 0% of holdings ($21.5M position)2M shares leftFirst sale on recordFiling

  2. 2 Form 4 sale AGENUnusual
    Apr 29, 2015 +638 days

    Sold 1.1M shares at $7.11 ($7.9M)

    Malik Shahzad, Director

    Sold 100% of holdings ($7.9M position)0 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale Versartis, Inc.Plan not stated
    Mar 15, 2017 +686 days

    Sold 166,330 shares at $19.09 ($3.2M)

    Malik Shahzad, Director

    Sold 7.3% of holdings ($43.4M position)2.1M shares leftFirst sale on recordFiling

  4. 4 Form 4 sale Versartis, Inc.Plan not stated
    Mar 17, 2017 +2 days

    Sold 483,670 shares at $18.11 ($8.8M)

    Malik Shahzad, Director

    Sold 23% of holdings ($38.1M position)1.6M shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Malik Shahzad
Source
Mar 17, 2017Mar 17, 2017Versartis, Inc.DirectorForm 4 sale483,670$8.8M23.0%Plan not statedSEC
Mar 15, 2017Mar 15, 2017Versartis, Inc.DirectorForm 4 sale166,330$3.2M7.3%Plan not statedSEC
Apr 29, 2015Apr 30, 2015AGENDirectorForm 4 sale1.1M$7.9M100.0%UnusualSEC
Jul 30, 2013Aug 1, 2013Conatus Pharmaceuticals IncDirector, 10% ownerForm 4 sale535$6k0.0%Plan not statedSEC